Gene transfer into mammalian cells using targeted filamentous bacteriophage

Cold Spring Harbor Protocols

Volumn 6, Issue 8, 2011, Pages 950-957

  Baird, Andrew ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AVIDIN; BIOTIN; ENDOTOXIN; VIRUS VECTOR;

ARTICLE; BACTERIOPHAGE; BACTERIUM CULTURE; BACTERIUM TRANSFORMATION; BIOSAFETY; CELL TRANSFER; COMBINATORIAL CHEMISTRY; CULTURE TECHNIQUE; GENE LIBRARY; GENE TARGETING; GENETIC STABILITY; GENOTOXICITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MAMMAL CELL; NONHUMAN; PHAGE DISPLAY; PHASE PARTITIONING; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; PROTEIN EXPRESSION; VIRAL GENE DELIVERY SYSTEM; ANIMAL; CELL LINE; CYTOLOGY; GENE TRANSFER; GENETICS; INOVIRIDAE; MAMMAL; METHODOLOGY; MOLECULAR BIOLOGY;

FILAMENTOUS BACTERIOPHAGE; MAMMALIA;

ANIMALS; CELL LINE; CYTOLOGICAL TECHNIQUES; GENE TRANSFER TECHNIQUES; HUMANS; INOVIRUS; MAMMALS; MOLECULAR BIOLOGY;

EID: 79961216911     PISSN: None     EISSN: 15596095     Source Type: Journal    
DOI: 10.1101/pdb.prot5653     Document Type: Article

References (44)

1. Baker ML, Jiang W, Rixon FJ, Chiu W. 2005. Common ancestry of herpesviruses and tailed DNA bacteriophages. J Virol 79: 14967-14970.
2. Bamford DH, Burnett RM, Stuart DI. 2002. Evolution of viral structure. Theor Popul Biol 61: 461-470.
3. Barry MA, Dower WJ, Johnston SA. 1996. Toward cell-targeting gene therapy vectors: Selection of cell-binding peptides from random peptide-presenting phage libraries. Nat Med 2: 299-305.
4. Bass S, Greene R, Wells JA. 1990. Hormone phage: An enrichment method for variant proteins with altered binding properties. Proteins 8: 309-314.
5. Becerril B, Poul MA, Marks JD. 1999. Toward selection of internalizing antibodies from phage libraries. Biochem Biophys Res Commun 255: 386-393.
6. Briones C, Bastolla U. 2005. Protein evolution in viral quasispecies under selective pressure: A thermodynamic and phylogenetic analysis. Gene 47: 237-246.
7. Bruttin A, Brussow H. 2005. Human volunteers receiving Escherichia coli phage T4 orally: A safety test of phage therapy. Antimicrob Agents Chemother 49: 2874-2878.
8. Buchli PJ, Wu Z, Ciardelli TL. 1997. The functional display of interleukin-2 on filamentous phage. Arch Biochem Biophys 339: 79-84.
9. Burg MA, Jensen-Pergakes K, Gonzalez AM, Ravey P, Baird A, Larocca D. 2002. Enhanced phagemid particle gene transfer in camptothecintreated carcinoma cells. Cancer Res 62: 977-981.
10. Burg M, Ravey EP, Gonzales M, Amburn E, Faix PH, Baird A, Larocca D. 2004. Selection of internalizing ligand-display phage using rolling circle amplification for phage recovery. DNA Cell Biol 23: 457-462.
11. Casjens SR. 2005. Comparative genomics and evolution of the tailedbacteriophages. Curr Opin Microbiol 8: 451-458.
12. Cormack BP, Valdivia RH, Falkow S. 1996. FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173: 33-38.
13. Cwirla SE, Peters EA, Barrett RW, Dower WJ. 1990. Peptides on phage: A vast library of peptides for identifying ligands. Proc Natl Acad Sci 87: 6378-6382.
14. Geier MR, Trigg ME, Merril CR. 1973. Fate of bacteriophage lambda in non-immune germ-free mice. Nature 246: 221-223.
15. Giebel LB, Cass RT, Milligan DL, Young DC, Arze R, Johnson CR. 1995. Screening of cyclic peptide phage libraries identifies ligands that bind streptavidin with high affinities. Biochemistry 34: 15430-15435.
16. Gram H, Strittmatter U, Lorenz M, Gluck D, Zenke G. 1993. Phage display as a rapid gene expression system: Production of bioactive cytokine-phage and generation of neutralizing monoclonal antibodies. J Immunol Methods 161: 169-176.
17. Hambly E, Suttle CA. 2005. The viriosphere, diversity, and genetic exchange within phage communities. Curr Opin Microbiol 8: 444-450.
18. Ivanenkov VV, Felici F, Menon AG. 1999. Targeted delivery of multivalent phage display vectors into mammalian cells. Biochim Biophys Acta 1448: 463-472.
19. Kassner PD, Burg MA, Baird A, Larocca D. 1999. Genetic selection of phage engineered for receptor-mediated gene transfer to mammalian cells. Biochem Biophys Res Commun 264: 921-928.
20. Kehoe JW, Kay BK. 2005. Filamentous phage display in the new millennium. Chem Rev 105: 4056-4072.
21. Larocca D, Witte A, Johnson W, Pierce GF, Baird A. 1998. Targeting bacteriophage to mammalian cell surface receptors for gene delivery. Hum Gene Ther 9: 2393-2399.
22. Larocca D, Kassner PD, Witte A, Ladner RC, Pierce GF, Baird A. 1999. Gene transfer to mammalian cells using genetically targeted filamentous bacteriophage. FASEB J 13: 727-734.
23. Larocca D, Jensen-Pergakes K, Burg MA, Baird A. 2001. Receptortargeted gene delivery using multivalent phagemid particles. Mol Ther 3: 476-484.
24. Larocca D, Jensen-Pergakes K, Burg MA, Baird A. 2002. Gene transfer using targeted filamentous bacteriophage. Methods Mol Biol 185: 393-401.
25. Larocca D, Burg MA, Jensen-Pergakes K, Ravey EP, Gonzalez AM, Baird A. 2002. Evolving phage vectors for cell targeted gene delivery. Curr Pharm Biotechnol 3: 45-57.
26. Merlin S, Rowold E, Abegg A, Berglund C, Klover J, Staten N, McKearn JP, Lee SC. 1997. Phage presentation and affinity selection of a deletion mutant of human interleukin-3. Appl Biochem Biotechnol 67: 199-214.
27. Merril CR, Biswas B, Carlton R, Jensen NC, Creed GJ, Zullo S, Adhya S. 1996. Long-circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci 93: 3188-3192.
28. Molenaar TJ, Michon I, de Haas SA, van Berkel TJ, Kuiper J, Biessen EA. 2002. Uptake and processing of modified bacteriophage M13 in mice: Implications for phage display. Virology 293: 182-191.
29. Mount JD, Samoylova TI, Morrison NE, Cox NR, Baker HJ, Petrenko VA. 2004. Cell targeted phagemid rescued by preselected landscape phage. Gene 341: 59-65.
30. Perabo L, Endell J, King S, Lux K, Goldnau D, Hallek M, Buning H. 2006. Combinatorial engineering of a gene therapy vector: Directed evolution of adeno-associated virus. J Gene Med 8: 155-162.
31. Pereira S, Maruyama H, Siegel D, Van Belle P, Elder D, Curtis P, Herlyn D. 1997. Amodel system for detection and isolation of a tumor cell surface antigen using antibody phage display. J Immunol Methods 203: 11-24.
32. Petrenko VA, Smith GP. 2000. Phages from landscape libraries as substitute antibodies. Protein Eng 13: 589-592.
33. Poul MA, Marks JD. 1999. Targeted gene delivery to mammalian cells by filamentous bacteriophage. J Mol Biol 288: 203-211.
34. Rakonjac J, Jovanovic G, Model P. 1997. Filamentous phage infectionmediated gene expression: Construction and propagation of the gIII deletion mutant helper phage R408d3. Gene 198: 99-103.
35. Saggio I, Gloaguen I, Laufer R. 1995. Functional phage display of ciliary neurotrophic factor. Gene 152: 35-39.
36. Scott JK, Smith GP. 1990. Searching for peptide ligands with an epitope library. Science 249: 386-390.
37. Skiena SS. 2001. Designing better phages. Bioinformatics (suppl.) 1: S253-S261. Smith GP. 1985. Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface. Science 228: 1315-1317.
38. Smith GP, Scott JK. 1993. Libraries of peptides and proteins displayed on filamentous phage. Methods Enzymol 217: 228-257.
39. Souriau C, Fort P, Roux P, Hartley O, Lefranc MP, Weill M. 1997. A simple luciferase assay for signal transduction activity detection of epidermal growth factor displayed on phage. Nucleic Acids Res 25: 1585-1590.
40. Spear MA, Schuback D, Miyata K, Grandi P, Sun F, Yoo L, Nguyen A, Brandt CR, Breakefield XO. 2003. HSV-1 amplicon peptide display vector. J Virol Methods 107: 71-79.
41. Vispo NS, Callejo M, Ojalvo AG, Santos A, Chinea G, Gavilondo JV, Arana MJ. 1997. Displaying human interleukin-2 on the surface of bacteriophage. Immunotechnology 3: 185-193.
42. Vitiello CL, Merril CR, Adhya S. 2005. An amino acid substitution in a capsid protein enhances phage survival in mouse circulatory system more than a 1000-fold. Virus Res 114: 101-103.
43. Watters JM, Telleman P, Junghans RP. 1997. An optimized method for cell-based phage display panning. Immunotechnology 3: 21-29.
44. Yalkinoglu AO, Heilbronn R, Burkle A, Schlehofer JR, Zur Hausen H. 1988. DNA amplification of adeno-associated virus as a response to cellular genotoxic stress. Cancer Res 48: 3123-3129.